Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Waltermire Robert E.. Insider active across 1 company, notably Madrigal Pharmaceuticals, INC.. In total, 13 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €716k. Activity tracked since 16 January 2023. The latest transaction was filed on 5 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Waltermire Robert E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
6,825 shares@ US$87.9223.5% of flowCommon StockSEC:0001628280-25-011405:0
1,052 shares@ US$340.985714.4% of flowCommon StockSEC:0001628280-25-010224:0
103 shares@ US$335.241.4% of flowCommon StockSEC:0001628280-25-002655:0
442 shares@ US$273.414.9% of flowCommon StockSEC:0001628280-25-001900:0
1,900 shares@ US$87.096.4% of flowCommon StockSEC:0000950170-24-075221:0
2,000 shares@ US$87.926.8% of flowCommon StockSEC:0000950170-24-073969:0
1,036 shares@ US$231.349.2% of flowCommon StockSEC:0000950170-24-064271:0
1,419 shares0Common StockSEC:0000950170-24-007559:0
550 shares@ US$243.925.1% of flowCommon StockSEC:0000950170-24-005294:0
2,000 shares@ US$87.926.7% of flowCommon StockSEC:0000950170-23-071116:0
1,300 shares@ US$87.924.4% of flowCommon StockSEC:0000950170-23-070416:0
5,000 shares@ US$87.9217.2% of flowCommon StockSEC:0000899243-23-006751:0
5,667 shares0Common StockSEC:0000899243-23-002098:0
About Waltermire Robert E.
Waltermire Robert E. is Senior VP, Chief Pharma Dev. at Madrigal Pharmaceuticals, INC. He has 13 filings in total. Across the 13 sampled recent filings, the sell amount is EUR 716325, the date range runs from 2023-01-18 to 2025-03-07, and the most frequent transaction nature is Levée d'options.